Maladies autoimmunes dans le contexte de la pandémie COVID-19 [Autoimmune diseases in the context of pandemic COVID-19]
Détails
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_23C4ADC982B0
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Maladies autoimmunes dans le contexte de la pandémie COVID-19 [Autoimmune diseases in the context of pandemic COVID-19]
Périodique
Revue medicale suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
29/04/2020
Peer-reviewed
Oui
Volume
16
Numéro
N° 691-2
Pages
827-830
Langue
français
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Publication Status: ppublish
Résumé
Patient suffering from autoimmune diseases (AID) typically have an increased risk of infection, which is attributed to the disease itself, but also to immunosuppressive drugs (IS) and comorbidities. During the current COVID-19 outbreak, the way to manage these diseases remains elusive. Limited data is currently available on AID and IS in the context of this new coronavirus infection. To date, there is no evidence to support an increase in complications of COVID-19 in these patients. In addition, certain drugs that are commonly used to treat AID could be part of the therapeutic arsenal used in COVID-19. The purpose of this article is to review the unique aspects of patients with AID during the COVID-19 outbreak.
Mots-clé
Autoimmune Diseases/complications, Autoimmune Diseases/therapy, Betacoronavirus, Coronavirus Infections/complications, Coronavirus Infections/epidemiology, Humans, Pandemics, Pneumonia, Viral/complications, Pneumonia, Viral/epidemiology
Pubmed
Création de la notice
02/05/2020 14:56
Dernière modification de la notice
20/08/2022 7:08